Clinical Trials Directory

Trials / Completed

CompletedNCT04515056

Characterization of New Human Models of Non-histaminergic Itch

Characterization of New Human Models of Non-histaminergic Itch and Their Interaction With the TRPM8 Receptor

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Aalborg University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

In this experiment the investigators would like to test a new new human itch model based on papain, and to characterize the sensory quality and temporary aspects of papain skin prick test (SPT) in comparison to the inactivated-cowhage delivery system.

Detailed description

The most used model of non-histaminergic itch is cowhage but this models presents several problems, such us the impossibility of standardizing the amount of the spicules inserted in the skin and the difficulty of obtaining the substance. These aspects bring us the necessity to find a new and more standardized model of non-histaminergic itch. Papain is a cysteine protease extracted from papaya plant that is known to cause itch if applied to the skin. For these reasons the investigators would like to test a new new human itch model based on papain, and to characterize the sensory quality and temporary aspects of papain skin prick test (SPT) in comparison to the inactivated-cowhage delivery system.

Conditions

Interventions

TypeNameDescription
DRUGPapain 10 µgThe area will be exposed to 10 µg of papain.
DRUGPapain 50 µgThe area will be exposed to 50 µg of papain.
DRUGPapain 100 µgThe area will be exposed to 100 µg of papain.
OTHERVehicleThe area will be exposed to vehicle
DRUGPapain 1 SPTPapain will be applied by 1 SPT prick thought the skin
DRUGPapain 5 SPTPapain will be applied by 5 SPT pricks thought the skin
DRUGPapain 25 SPTPapain will be applied by 25 SPT pricks thought the skin
OTHERCowhageThe last area will be exposed to cowage spicules (made chemically inert by autoclaving) soaked in 5 mg/ml papain solution.

Timeline

Start date
2020-09-01
Primary completion
2021-06-01
Completion
2021-06-01
First posted
2020-08-17
Last updated
2021-07-09

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04515056. Inclusion in this directory is not an endorsement.